161 related articles for article (PubMed ID: 18166225)
1. G-CSF-induced remission in two cases of acute myeloid leukemia.
Benz R; Goede JS; Parlier V; Mühlematter D; Jotterand M; Fehr J
Leuk Res; 2008 Jul; 32(7):1148-52. PubMed ID: 18166225
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood and bone marrow changes after treatment with ATRA and G-CSF in AML, APL and blast crisis following Vaquez's disease.
Notario A; Rolandi ML; Mazzucchelli I
Haematologica; 1996; 81(3):261-4. PubMed ID: 8767533
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia.
Zhang WG; Wang FX; Chen YX; Cao XM; He AL; Liu J; Ma XR; Zhao WH; Liu SH; Wang JL
Am J Hematol; 2008 Mar; 83(3):185-8. PubMed ID: 17899614
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.
Walker AR; Komrokji RS; Ifthikharuddin J; Messina P; Mulford D; Becker M; Friedberg J; Oliva J; Phillips G; Liesveld JL; Abboud C
Leuk Res; 2008 Dec; 32(12):1830-6. PubMed ID: 18571721
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic effect of priming induction regimen of CAG for newly diagnosed acute myeloid leukemia in elderly patients].
Chen YJ; Zhang LQ; Li XL; Zhao XL; Wu DS; Shu YG; Chen FP
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 33(3):245-51. PubMed ID: 18382060
[TBL] [Abstract][Full Text] [Related]
7. Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy.
Kanemura N; Tsurumi H; Kasahara S; Hara T; Yamada T; Sawada M; Goto N; Kitagawa J; Shimizu M; Oyama M; Moriwaki H
Hematol Oncol; 2008 Mar; 26(1):33-8. PubMed ID: 17918772
[TBL] [Abstract][Full Text] [Related]
8. Remission induction by granulocyte colony-stimulating factor in hypoplastic acute myelogenous leukemia complicated by infection. A case report and review of the literature.
Takamatsu Y; Miyamoto T; Iwasaki H; Makino S; Tamura K
Acta Haematol; 1998; 99(4):224-30. PubMed ID: 9644302
[TBL] [Abstract][Full Text] [Related]
9. Application of recombinant human granulocyte colony stimulating factor in children with acute myeloid leukemia.
Shang X; Yin H; Lu A; Zhang L
Chin Med J (Engl); 1999 Jul; 112(7):620-2. PubMed ID: 11601256
[TBL] [Abstract][Full Text] [Related]
10. Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.
Wierzbowska A; Robak T; Pluta A; Wawrzyniak E; Cebula B; Hołowiecki J; Kyrcz-Krzemień S; Grosicki S; Giebel S; Skotnicki AB; Piatkowska-Jakubas B; Kuliczkowski K; Kiełbiński M; Zawilska K; Kłoczko J; Wrzesień-Kuś A;
Eur J Haematol; 2008 Feb; 80(2):115-26. PubMed ID: 18076637
[TBL] [Abstract][Full Text] [Related]
11. Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.
Kalaycio M; Advani A; Pohlman B; Sekeres M; Tripp B; Rybicki L; Sobecks R
Am J Hematol; 2008 Nov; 83(11):831-4. PubMed ID: 18756545
[TBL] [Abstract][Full Text] [Related]
12. Transient atypical monocytosis mimic acute myelomonocytic leukemia in post-chemotherapy patients receiving G-CSF: report of two cases.
Liu CZ; Persad R; Inghirami G; Sen F; Amorosi E; Goldenberg A; Ibrahim S
Clin Lab Haematol; 2004 Oct; 26(5):359-62. PubMed ID: 15485468
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
[TBL] [Abstract][Full Text] [Related]
14. [Complete remission in acute myeloblastic leukemia (M0) after treatment with rhG-CSF].
Maeda A; Yoshinaga N; Hirata H; Asagoe K; Nohgawa M; Takano K; Harakawa N; Nakabo Y; Takahashi A; Yamamoto K
Rinsho Ketsueki; 1995 Jan; 36(1):45-9. PubMed ID: 7536276
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of priming with granulocyte macrophage colony-stimulating factor plus all-trans retinoic acid combined with remission induction chemotherapy in patients with acute myeloid leukemia.
Shin HJ; Chung JS; Choi YJ; Cho GJ
Am J Clin Oncol; 2009 Jun; 32(3):227-32. PubMed ID: 19433969
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy with ubenimex corresponding to patient age and organ disorder for 18 cases of acute myelogeneous leukemia in elderly patients--effects, complications and long-term survival].
Hirayama Y; Sakamaki S; Takayanagi N; Tsuji Y; Sagawa T; Chiba H; Matsunaga T; Niitsu Y
Gan To Kagaku Ryoho; 2003 Aug; 30(8):1113-8. PubMed ID: 12938265
[TBL] [Abstract][Full Text] [Related]
17. Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia.
Montillo M; Ricci F; Tedeschi A; Cafro AM; Nosari AM; Nichelatti M; Marbello L; Morra E
Leuk Res; 2009 Aug; 33(8):1072-8. PubMed ID: 19187960
[TBL] [Abstract][Full Text] [Related]
18. Two patients with nonimmune chronic idiopathic neutropenia of adults developing acute myeloid leukemia with aberrant phenotype and complex karyotype but no mutations in granulocyte colony-stimulating factor receptor.
Papadaki HA; Kosteas T; Gemetzi C; Alexandrakis M; Psyllaki M; Eliopoulos GD
Ann Hematol; 2002 Jan; 81(1):50-4. PubMed ID: 11807637
[TBL] [Abstract][Full Text] [Related]
19. Hematological remission and long term hematological control of acute myeloblastic leukemia induced and maintained by granulocyte-colony stimulating factor (G-CSF) therapy.
Xavier L; Cunha M; Gonçalves C; Teixeira Mdos A; Coutinho J; Ribeiro AC; Lima M
Leuk Lymphoma; 2003 Dec; 44(12):2137-42. PubMed ID: 14959860
[TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of achieving cytogenetic remission in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome following induction chemotherapy.
Balleisen S; Kuendgen A; Hildebrandt B; Haas R; Germing U
Leuk Res; 2009 Sep; 33(9):1189-93. PubMed ID: 19428106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]